Found 11 matching trials
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency PHASE3 This study will assess the efficacy and safety of capivasertib plus abirate...
Show More Status
Active Not Recruiting
Learn More & Join Trial
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer PHASE2 This is a prospective, open-label, multi-center seamless phase II to phase ...
Show More Location
VA Long Beach Healthcare System, Long Beach, CA
Learn More & Join Trial
A Comparative Dose-finding Study of RS-113 in Patients With Metastatic Castration-resistant Prostate Cancer PHASE2 The primary objective of the study is to determine the therapeutic dose of ...
Show More Status
Active Not Recruiting
Location
State Budgetary Healthcare Institution of the Arkhangelsk Region "Arkhangelsk Oncology Dispensary"
Learn More & Join Trial
Phase III Study of Abiraterone Acetate (II) Versus Abiraterone Acetate in Patients with MCRPC PHASE3 Acetate abiraterone tablets (II) is a modified new drug launched in China, ...
Show More Location
Fudan University Shanghai Cancer Center
Learn More & Join Trial
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy PHASE2 The overall aim of this trial, which is called STAMPEDE, is to assess novel...
Show More Status
Active Not Recruiting
Location
Lausanne Centre Hospitalier Universitaire
Learn More & Join Trial
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer PHASE2 This is a prospective, multicenter, multi-arm, non-randomized, open-label c...
Show More Location
Department of Urology, Drum Tower Hospital, Medical School of Nanjing University, Institute of Urology, Nanjing University
Learn More & Join Trial
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation PHASE3 The purpose of the study is to demonstrate superiority of Saruparib (AZD530...
Show More Learn More & Join Trial
A Study of ARV-766 Given by Mouth in Men With Metastatic Prostate Cancer PHASE1 This first-in-human, Phase 1/2, open-label study evaluates the safety, tole...
Show More Status
Active Not Recruiting
Location
City of Hope National Medical
Learn More & Join Trial
A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer PHASE3 STAMPEDE2 is a clinical trial comparing two new treatments with standard of...
Show More Location
Mount Vernon Hospital
Learn More & Join Trial
Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate PHASE2 Neoadjuvant treatment before radical prostatectomy has been proven to provi...
Show More Location
West China Hospital
Learn More & Join Trial